XML 17 R6.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Cash Flows from Operating Activities    
Net income (loss) $ (31,365) $ 3,321
Adjustments to reconcile net income (loss) to net cash and cash equivalents from operating activities:    
Depreciation and amortization 4,906 1,782
Amortization of right-of-use assets 372 16
Stock compensation expense 5,145 3,910
Deferred taxes   13
Change in fair value of warrant liabilities (2,325) (28,183)
Amortization of premiums and accretion of discounts on marketable securities (5,518)  
Change in operating assets and liabilities that provided (used) cash and cash equivalents:    
Contract receivable (3,383) (1,202)
Prepaid expenses and other assets (188) 744
Accounts payable and other accrued liabilities (297) (4,261)
Deferred revenue (4,032) (286)
Accrued expenses 649 1,000
Lease liabilities (268) 188
Net cash and cash equivalents used in operating activities (36,304) (22,958)
Cash Flows from Investing Activities    
Purchases of property, plant and equipment (21,184) (30,957)
Purchases of marketable securities and long-term investments (174,400) (212,792)
Proceeds from sales of marketable securities 210,329 54,819
Purchases of intangible assets (259) (228)
Net cash and cash equivalents provided by (used in) investing activities 14,486 (189,158)
Cash Flows from Financing Activities    
Payments of debt (7) (71)
Proceeds from exercise of stock options 184 354
Proceeds from issuance of common stock under ESPP 214 0
Receivable for exercise of stock options   79
Cash paid for withholding of employee taxes related to stock-based compensation (111) (58)
Payments on finance lease liability (146) (20)
Transaction costs   (12)
Net cash and cash equivalents provided by financing activities 134 272
Net (decrease) in cash and cash equivalents (21,684) (211,844)
Cash and cash equivalents at beginning of period 50,123 513,447
Cash and cash equivalents at end of period 28,439 301,603
Supplemental information    
Cash paid for interest 26 5
Accrued capital expenditures $ 3,591 $ 8,146